Identification of Synthetically Immunogenic Compounds to Synergize with Immunotherapy in Neuroblastoma |
Children’s Hospital of Philadelphia / Adam Wolpaw, MD/PhD |
Young Investigator Grants |
2019 |
Pennsylvania |
Optimizing TCRαβ+/CD19+-depleted haploidentical HSCT for ALL using donor-derived genome-edited CAR T cells |
Stanford University School of Medicine / Alice Bertaina, MD/PhD |
Reach Grants |
2019 |
California |
Single-cell Gene Expression and Cytosine Modification Profiling in Pediatric Central Nervous System Tumors |
Dartmouth College / Brock Christensen, PhD |
Single-cell Pediatric Cancer Atlas Grant |
2019 |
New Hampshire |
Enhancing the therapeutic efficacy of chimeric antigen receptor T cells for acute myeloid leukemia |
Washington University / Miriam Kim, MD |
Young Investigator Grants |
2019 |
Missouri |
Multivalent Nanomedicine to Treat High-Risk Pediatric Solid Tumors |
Children’s Hospital of Philadelphia / Garrett Brodeur, MD |
Reach Grants |
2019 |
Pennsylvania |
Kidney Disease after CD19-Targeted Chimeric Antigen Receptor T Cell Therapy for Pediatric Acute Lymphoblastic Leukemia |
Children’s Hospital of Philadelphia / Regina Myers, MD |
Young Investigator Grants |
2019 |
Pennsylvania |
Targeting Spinal Ependymoma and Other Gliomas Using Novel Genetically Defined Models |
The Johns Hopkins University School of Medicine / Charles Eberhart, MD, PhD |
Catalyst Grants |
2019 |
Maryland |
Exploiting the Differentiation Potential of Pediatric High-Grade Glioma to Discover Novel Therapeutic Opportunities |
Dana-Farber Cancer Institute / Mariella Filbin, MD/PhD |
'A' Award Grants |
2019 |
Massachusetts |
Using Splice Switching Oligonucleotides (SSOs) to target MDM2 for rhabdomyosarcoma therapy |
Research Institute at Nationwide Children's Hospital / Dawn Chandler, PhD |
Innovation Grants |
2019 |
Ohio |
Therapeutic Targeting of the Disrupted Metabolic State in DIPG |
University of Michigan / Costas Lyssiotis, PhD & Sriram Venneti, MD/PhD |
Innovation Grants |
2019 |
Michigan |